Search Results - "Kwek, Serena S"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire by Oh, David Y, Cham, Jason, Zhang, Li, Fong, Grant, Kwek, Serena S, Klinger, Mark, Faham, Malek, Fong, Lawrence

    Published in Cancer research (Chicago, Ill.) (15-03-2017)
    “…While immune checkpoint blockade elicits efficacious responses in many patients with cancer, it also produces a diverse and unpredictable number of…”
    Get full text
    Journal Article
  3. 3

    GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses by Kwek, Serena S., Kahn, James, Greaney, Samantha K., Lewis, Jera, Cha, Edward, Zhang, Li, Weber, Robert W., Leonard, Lonnie, Markovic, Svetomir N., Fong, Lawrence, Spitler, Lynn E.

    Published in Oncoimmunology (02-04-2016)
    “…We conducted a phase II clinical trial of anti-CTLA-4 antibody (ipilimumab) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in 22 patients with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Systemic Immunity Is Required for Effective Cancer Immunotherapy by Spitzer, Matthew H., Carmi, Yaron, Reticker-Flynn, Nathan E., Kwek, Serena S., Madhireddy, Deepthi, Martins, Maria M., Gherardini, Pier Federico, Prestwood, Tyler R., Chabon, Jonathan, Bendall, Sean C., Fong, Lawrence, Nolan, Garry P., Engleman, Edgar G.

    Published in Cell (26-01-2017)
    “…Immune responses involve coordination across cell types and tissues. However, studies in cancer immunotherapy have focused heavily on local immune responses in…”
    Get full text
    Journal Article
  6. 6

    Unmasking the immune recognition of prostate cancer with CTLA4 blockade by Kwek, Serena S., Cha, Edward, Fong, Lawrence

    Published in Nature reviews. Cancer (01-04-2012)
    “…Cytotoxic T lymphocyte-associated antigen 4 (CTLA4) represents a crucial immune checkpoint, the blockade of which can potentiate anti-tumour immunity. This…”
    Get full text
    Journal Article
  7. 7

    Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function by Rancan, Chiara, Arias-Badia, Marcel, Dogra, Pranay, Chen, Brandon, Aran, Dvir, Yang, Hai, Luong, Diamond, Ilano, Arielle, Li, Jacky, Chang, Hewitt, Kwek, Serena S., Zhang, Li, Lanier, Lewis L., Meng, Maxwell V., Farber, Donna L., Fong, Lawrence

    Published in Nature immunology (01-04-2023)
    “…Gamma delta (γδ) T cells reside within human tissues including tumors, but their function in mediating antitumor responses to immune checkpoint inhibition is…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients by Kwek, Serena S, Dao, Vinh, Roy, Ritu, Hou, Yafei, Alajajian, David, Simko, Jeffrey P, Small, Eric J, Fong, Lawrence

    Published in The Journal of immunology (1950) (01-10-2012)
    “…CTLA-4 is a surface receptor on activated T cells that delivers an inhibitory signal, serving as an immune checkpoint. Treatment with anti-CTLA-4 Abs can…”
    Get full text
    Journal Article
  10. 10

    Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF by FONG, Lawrence, KWEK, Serena S, SMALL, Eric J, O'BRIEN, Shaun, KAVANAGH, Brian, MCNEEL, Douglas G, WEINBERG, Vivian, LIN, Amy M, ROSENBERG, Jonathan, RYAN, Charles J, RINI, Brian I

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…CTL-associated antigen 4 (CTLA4) is a costimulatory molecule expressed on activated T cells that delivers an inhibitory signal to these T cells. CTLA4 blockade…”
    Get full text
    Journal Article
  11. 11

    Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma by Wustrack, Rosanna L., Shao, Evans, Sheridan, Joey, Zimel, Melissa, Cho, Soo-Jin, Horvai, Andrew E., Luong, Diamond, Kwek, Serena S., Fong, Lawrence, Okimoto, Ross A.

    Published in Cancer Immunology, Immunotherapy (01-10-2021)
    “…Background Soft-tissue sarcomas (STS) are a rare group of mesenchymal malignancies that account for approximately 1% of adult human cancer. Undifferentiated…”
    Get full text
    Journal Article
  12. 12

    Functional analysis and intracellular localization of p53 modified by SUMO-1 by KWEK, Serena S. S, DERRY, Jason, TYNER, Angela L, ZHIYUAN SHEN, GUDKOV, Andrei V

    Published in Oncogene (03-05-2001)
    “…p53 tumor suppressor is a subject of several post-translational modifications, including phosphorylation, ubiquitination and acetylation, which regulate p53…”
    Get full text
    Journal Article
  13. 13

    Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab by Kwek, Serena S, Lewis, Jera, Zhang, Li, Weinberg, Vivian, Greaney, Samantha K, Harzstark, Andrea L, Lin, Amy M, Ryan, Charles J, Small, Eric J, Fong, Lawrence

    Published in Cancer immunology research (01-09-2015)
    “…Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blockade can induce tumor regression and improved survival in cancer patients. This treatment can enhance…”
    Get more information
    Journal Article
  14. 14

    Apoptosis Inhibitor as a Suppressor of Tumor Progression: Expression of Bcl-2 Eliminates Selective Advantages for p53-Deficient Cells in the Tumor by Gurova, Katerina V., Kwek, Serena S. S., Koman, Igor E., Komarov, Andrei P., Kandel, Eugene, Nikiforov, Mikhail A., Gudkov, Andrei V.

    Published in Cancer biology & therapy (01-01-2002)
    “…Inactivation of p53 and expression of Bcl-2, frequently occurring during tumor progression, have different prognostic value: while inactivation of p53 is…”
    Get full text
    Journal Article
  15. 15

    Abstract 4688: Single-cell discrimination of altered human T cell states in the bladder tumor microenvironment by Oh, David Yoonsuk, Kwek, Serena S., Mangul, Serghei, Raju, Siddharth S., Targ, Sasha, Burra, Arun, Chow, Eric, Aran, Dvir, Porten, Sima, Meng, Maxwell V., Friedlander, Terence W., Ye, Chun Jimmie, Fong, Lawrence

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Bladder cancer can be responsive to immunotherapies such as anti-PD-1 and anti-PD-L1 checkpoint inhibitors, but overall response rates are low…”
    Get full text
    Journal Article
  16. 16

    Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis by Kwek, S S, Roy, R, Zhou, H, Climent, J, Martinez-Climent, J A, Fridlyand, J, Albertson, D G

    Published in Oncogene (30-04-2009)
    “…Co-amplification at chromosomes 8p11–8p12 and 11q12–11q14 occurs often in breast tumors, suggesting possible cooperation between genes in these regions in…”
    Get full text
    Journal Article
  17. 17

    Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence by NIKIFOROV, M. A, KWEK, S. S. S, MEHTA, R, ARTWOHL, J. E, LOWE, S. W, TAPAS DAS GUPTA, DEICHMAN, G. I, GUDKOV, A. V

    Published in Oncogene (18-12-1997)
    “…Mutations in the p53 tumor suppressor gene are frequently associated with the metastatic stage of tumor progression. Inactivation of p53 was shown to promote…”
    Get full text
    Journal Article
  18. 18

    Structure and Regulation of the Mouse ing1 Gene by Zeremski, Marija, Hill, Jason E., Kwek, Serena S.S., Grigorian, Irina A., Gurova, Katerina V., Garkavtsev, Igor V., Diatchenko, Luda, Koonin, Eugene V., Gudkov, Andrei V.

    Published in The Journal of biological chemistry (05-11-1999)
    “…The human ING1 gene encodes nuclear protein p33ING1, previously shown to cooperate with p53 in cell growth control (Garkavtsev, I., Grigorian, I. A.,…”
    Get full text
    Journal Article